Unilever Investor Event Presentation Deck

Unilever Continued progress in line with strategic priorities Win with brands and innovation 12 €1bn+ brands 51% of turnover 14% Q3'22 USG Move portfolio into high growth spaces Prestige and Health & Wellbeing grew double-digit Acquired Nutrafol Tea sale completed Accelerate USA, India, China and EMS Q3'22 USG 8.6% 16.1% 1.1% Emerging Markets 13.3% Lead in channels of the future 14% eCom % TO 20% eCom Q3'22 USG 6

View entire presentation